Abstract
Photobiomodulation (PBM) is an evidence-based approach for managing oral mucositis (OM) in patients undergoing head and neck radiotherapy (RT), though its biological mechanisms remain under investigation. This study evaluated salivary oxidative stress (OS) and inflammatory biomarkers in patients with head and neck squamous cell carcinoma (HNSCC) who received intraoral (IOPBM, n = 10) or extraoral PBM (EOPBM, n = 8) as supportive therapy during radiotherapy, and not as a cancer treatment. Preventive IOPBM/EOPBM were applied five times weekly from RT initiation until OM healing. Twenty healthy individuals served as the control group. Unstimulated saliva was collected at pre-, mid-, and final-RT (last RT session) to assess myeloperoxidase (MPO), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH), interleukin-6 (IL-6), and interleukin-10 (IL-10). HNSCC patients exhibited altered oxidative and inflammatory biomarker profiles during RT. MDA levels showed a transient increase at mid-RT (p < 0.05), particularly in the IOPBM group, but were not associated with OM severity (p > 0.05). MPO activity was significantly higher at all RT time points and across OM severity grades compared with CT (p < 0.05–0.01). In contrast, SOD activity were consistently elevated throughout RT in PBM-treated patients compared with CT (p < 0.001), and GSH levels increased at mid-RT (p < 0.01). IL-6 and IL-10 levels decreased from pre- to final-RT compared to CT (p < 0.05). Clinically, all patients developed OM, although fewer than 40% experienced severe OM. These findings suggest that PBM enhances antioxidant defenses and modulates inflammatory responses, supporting its role in reducing RT-induced oral toxicity.
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable request.
References
Villa, A. & Sonis, S. T. Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis. Expert Opin. Investig. Drugs. 27 (2), 147–154 (2018).
Liu, S. et al. Status of treatment and prophylaxis for radiation-induced oral mucositis in patients with head and neck cancer. Front. Oncol. 11, 642575 (2021).
Sardaro, N. et al. Oxidative stress and oral mucosal diseases: An overview. In Vivo 33(2), 289–296 (2019).
Choudhari, S. K. et al. Oxidative and antioxidative mechanisms in oral cancer and precancer: A review. Oral Oncol. 50(1), 10–18 (2014).
Mohammed, A. I. et al. Assessment of oxidative stress-induced oral epithelial toxicity. Biomolecules 13(8), 1239 (2023).
Sonis, S. T. A hypothesis for the pathogenesis of radiation-induced oral mucositis: When biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment. Support Care Cancer 29(9), 4939–4947 (2021).
Derindağ, G. et al. Evaluation of saliva glutathione, glutathione peroxidase, and malondialdehyde levels in head-neck radiotherapy patients. Turk. J. Med. Sci. 51(2), 644–649 (2021).
Gonzaga, A. K. G. et al. Oxidative stress markers in the saliva of patients with oral lichen planus. Pathol. Res. Pract. 248, 154569 (2023).
Mármora, B. C. et al. Defocused high-power diode laser accelerates skin repair in a murine model through REDOX state modulation and reepithelization and collagen deposition stimulation. J. Photochem. Photobiol. B 225, 112332 (2021).
Thieme, S. et al. Comparison of photobiomodulation using either an intraoral or an extraoral laser on oral mucositis induced by chemotherapy in rats. Support. Care Cancer 28(2), 867–876 (2020).
Araújo, A. A. et al. Protective effect of Angiotensin II receptor blocker against oxidative stress and inflammation in an oral mucositis experimental model. J. Oral Pathol. Med. 47(10), 972–984 (2018).
McCord, J. M. & Edeas, M. A. SOD, oxidative stress and human pathologies: A brief history and a future vision. Biomed. Pharmacother. 59(4), 139–42 (2005).
Sonis, S. T. Superoxide dismutase as an intervention for radiation therapy-associated toxicities: Review and profile of Avasopasem Manganese as a treatment option for radiation-induced mucositis. Drug Des. Devel. Ther. 15, 1021–1029 (2021).
Liu, T. et al. Imbalanced GSH/ROS and sequential cell death. J. Biochem. Mol. Toxicol. 36(1), e22942 (2022).
Aratani, Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch. Biochem. Biophys. 640, 47–52 (2018).
Nijakowski, K. et al. Salivary alterations of myeloperoxidase in patients with systemic diseases: A systematic review. Int. J. Mol. Sci. 24(15), 12078 (2023).
M. M. M. et al. Evaluate the role of phosphodiesterase, myeloperoxidase and iron in oral cancer. Asian Pac. J. Cancer Prev. 25(11), 3921–3926 (2024).
Jelic, M. D. et al. Oxidative stress and its role in cancer. J. Cancer Res. Ther. 17(1), 22–28 (2021).
Martins, A. F. L. et al. The effect of photobiomodulation on nitrite and inflammatory activity in radiotherapy-induced oral mucositis: A randomized clinical trial. Lasers Surg. Med. 53(5), 671–683 (2021).
Kiyomi, A. et al. Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study. PLoS One 17(4), e0267092 (2022).
Xu, J. et al. Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer. Head Neck 45(5), 1122–1129 (2023).
Saraiva, M. & O’Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10 (3), 170–181 (2010).
Elad, S. et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126 (19), 4423–4431 (2020).
Zadik, Y. et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support. Care Cancer 27(10), 3969–3983 (2019).
Musttaf, R. A., Jenkins, D. F. L. & Jha, A. N. Assessing the impact of low level laser therapy (LLLT) on biological systems: A review. Int. J. Radiat. Biol. 95(2), 120–43 (2019).
Oton-Leite, A. F. et al. Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head Neck 34(3), 398–404 (2012).
Treister, N. S. et al. A feasibility study evaluating extraoral photobiomodulation therapy for prevention of mucositis in pediatric hematopoietic cell transplantation. Photomed. Laser Surg. 34(4), 178–84 (2016).
Ramos-Pinto, M. B. et al. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: A randomized, single-blind, controlled clinical trial. Support Care Cancer 29(11), 6495–6503 (2021).
Robijns, J. et al. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT Position paper 2022. Front. Oncol. 12, 927685 (2022).
Klein, I. P. et al. Intraoral vs. extraoral photobiomodulation therapy for oral mucositis in head and neck cancer patients: A multicenter, randomized, single-blind clinical trial. Support Care Cancer 33(10), 842 (2025).
Kauark-Fontes, E. et al. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: Interim analysis of a randomized, double-blind, clinical trial. Support Care Cancer 30(3), 2225–2236 (2022).
Ibrahim, S. S. et al. Clinical and biochemical assessment of the effect of glutamine in management of radiation induced oral mucositis in patients with head and neck cancer: Randomized controlled clinical trial. J. Stomatol. Oral Maxillofac. Surg. 125(3S), e101827 (2024).
Hassanein, F. E. A. et al. L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: A triple-blind randomized trial. J. Cancer Res. Clin. Oncol. 151(7), 198 (2025).
Abou-Bakr, A. et al. Frequency of periodontal disease in head and neck cancer patients after radiation therapy: A cross-sectional study. BMC Oral Health 25(1), 1008 (2025).
Abou-Bakr, A. et al. Prevalence of late xerostomia and hyposalivation with associated risk factors in survivors of head and neck cancer after radiotherapy: A multi-centric cross-sectional study. Radiat. Oncol. 20(1), 162 (2025).
Miyamoto, H. et al. The relationship between the severity of radiation-induced oral mucositis and the myeloperoxidase levels in rats. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 120(3), 329–36 (2015).
Anderson, C. M. et al. Two-year tumor outcomes of a Phase 2B, randomized, double-blind trial of Avasopasem Manganese (GC4419) versus placebo to reduce severe oral mucositis owing to concurrent radiation therapy and Cisplatin for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 114(3), 416–421 (2022).
Nguyen, H. et al. Oxidative stress and chemoradiation-induced oral mucositis: A scoping review of in vitro, in vivo and clinical studies. Int. J. Mol. Sci. 23(9), 4863 (2022).
Rupel, K. et al. Photobiomodulation at multiple wavelengths differentially modulates oxidative stress in vitro and in vivo. Oxid. Med. Cell. Longev. https://doi.org/10.1155/2018/6510159 (2018).
Oton-Leite, A. F. et al. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg. Med. 47 (4), 296–305 (2015).
Silva, G. B. et al. Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: A randomized preliminary study. Lasers Med. Sci. 30(1), 117–26 (2015).
Pilar, E. F. S. et al. Modulation of gene expression in skin wound healing by photobiomodulation therapy: A systematic review in vivo studies. Photodermatol. Photoimmunol. Photomed. 40(4), e12990 (2024).
Acknowledgements
This study was supported by Postgraduate Research Group of Porto Alegre Clinics Hospital (GPPG/FIPE: 2020-0189). We also acknowledge the Brazilian National Council for Scientific and Technological Development (CNPq). A.R.S.S., F.A.A and M.D.M. are research fellows of CNPq. This research was developed within the scope of the National Institute of Science and Technology in Translational Biophotonics in Dentistry(INCT-BIOFOTO BUCAL), funded under the CNPq/SECTICS/CAPES/FAPs Call No. 46/2024 – National Institutes of Science and TechnologyProgram, grant number 408830/2024-7, Brazil.
Author information
Authors and Affiliations
Contributions
Study design : F.J.A.L, M.D.M., F.A.A., A.C.P.R, A.R.S.S, M.A.T.M.; **Data collection** : F.J.A.L., I.P.K, M.B.R.P, A.F.G. **Data analysis** : F.J.A.L, A.A.A., S.B.R., M.D.M. **Manuscript preparation** : All authors; **Manuscript review** : All authors.
Corresponding author
Ethics declarations
Competing interests
M.D.M. would like to disclose that she serves at Azena Medical as a consultant. The other authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Loureiro, F.J.A., Klein, I.P., de Farias Gabriel, A. et al. Effect of intraoral and extraoral photobiomodulation on salivary oxidative stress and inflammatory cytokines in patients with radiotherapy-induced oral mucositis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-43141-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-43141-3
